Efficacy of high-versus moderate-dose statin therapy on lower extremity artery disease after revascularization

Creative Commons License

Kup A., Kanar B., Uslu A., Zehir R., Akaslan D., KEPEZ A.

MARMARA MEDICAL JOURNAL, cilt.35, sa.1, ss.36-41, 2022 (ESCI) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 35 Sayı: 1
  • Basım Tarihi: 2022
  • Doi Numarası: 10.5472/marumj.1056187
  • Dergi Adı: MARMARA MEDICAL JOURNAL
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, Academic Search Premier, CINAHL, EMBASE, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.36-41
  • Anahtar Kelimeler: Statin treatment, Percutaneous transluminal angioplasty, Peripheral artery disease, RISK-FACTORS, ATORVASTATIN, OUTCOMES, METAANALYSIS, SIMVASTATIN, ANGIOPLASTY
  • Marmara Üniversitesi Adresli: Evet

Özet

Aim: Statins are one of the most important agents in the treatment of atherosclerotic peripheral arterial disease. We aim to compare high - and moderate-dose stain therapy in patients with lower extremity artery disease (LEAD) who have undergone percutaneous transluminal angioplasty (PTA).